Suggested region and language based on your location
Your current region and language
Novo Nordisk participated in the PAS 2090 pilot to assess how it integrates into existing lifecycle assessment framework for pharmaceutical products.
“The publication of the PAS 2090 standard on Life Cycle Assessments is an important milestone towards driving sustainability in the pharma sector.”
Reach out and see how we can help guide you on your path to sustainable operational success.